# Dapsone

NDC: 51862-123
Generic name: Dapsone
Labeler / Manufacturer: Mayne Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20240214

FDA application: ANDA212383

## Active ingredients

- DAPSONE: 50 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51862-123"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51862-123
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc495e54-8917-42de-a9fa-1f961bd99d61